These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 33786950

  • 1. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
    Zimmer TS, Korotkov A, Zwakenberg S, Jansen FE, Zwartkruis FJT, Rensing NR, Wong M, Mühlebner A, van Vliet EA, Aronica E, Mills JD.
    Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
    [Abstract] [Full Text] [Related]

  • 2. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH, Mahadeo T, Bordey A.
    J Neurosci; 2019 Apr 03; 39(14):2762-2773. PubMed ID: 30700531
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.
    Di Nardo A, Kramvis I, Cho N, Sadowski A, Meikle L, Kwiatkowski DJ, Sahin M.
    J Neurosci; 2009 May 06; 29(18):5926-37. PubMed ID: 19420259
    [Abstract] [Full Text] [Related]

  • 6. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
    Grajkowska W, Kotulska K, Matyja E, Larysz-Brysz M, Mandera M, Roszkowski M, Domańska-Pakieła D, Lewik-Kowalik J, Jóźwiak S.
    Folia Neuropathol; 2008 May 06; 46(1):43-8. PubMed ID: 18368626
    [Abstract] [Full Text] [Related]

  • 7. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
    Arena A, Zimmer TS, van Scheppingen J, Korotkov A, Anink JJ, Mühlebner A, Jansen FE, van Hecke W, Spliet WG, van Rijen PC, Vezzani A, Baayen JC, Idema S, Iyer AM, Perluigi M, Mills JD, van Vliet EA, Aronica E.
    Brain Pathol; 2019 May 06; 29(3):351-365. PubMed ID: 30303592
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
    Yasin SA, Ali AM, Tata M, Picker SR, Anderson GW, Latimer-Bowman E, Nicholson SL, Harkness W, Cross JH, Paine SM, Jacques TS.
    Acta Neuropathol; 2013 Aug 06; 126(2):207-18. PubMed ID: 23728790
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Sun FJ, Zhang CQ, Chen X, Wei YJ, Li S, Liu SY, Zang ZL, He JJ, Guo W, Yang H.
    J Neuroinflammation; 2016 Apr 19; 13(1):85. PubMed ID: 27095555
    [Abstract] [Full Text] [Related]

  • 12. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J, Zhang C, Shi X, Wei Y, Liu L, Liu S, Yang H.
    Brain Dev; 2019 Nov 19; 41(10):829-838. PubMed ID: 31495513
    [Abstract] [Full Text] [Related]

  • 13. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.
    Talos DM, Kwiatkowski DJ, Cordero K, Black PM, Jensen FE.
    Ann Neurol; 2008 Apr 19; 63(4):454-65. PubMed ID: 18350576
    [Abstract] [Full Text] [Related]

  • 14. mTOR cascade activation distinguishes tubers from focal cortical dysplasia.
    Baybis M, Yu J, Lee A, Golden JA, Weiner H, McKhann G, Aronica E, Crino PB.
    Ann Neurol; 2004 Oct 19; 56(4):478-87. PubMed ID: 15455405
    [Abstract] [Full Text] [Related]

  • 15. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
    van Scheppingen J, Broekaart DW, Scholl T, Zuidberg MR, Anink JJ, Spliet WG, van Rijen PC, Czech T, Hainfellner JA, Feucht M, Mühlebner A, van Vliet EA, Aronica E.
    J Neuroinflammation; 2016 Aug 26; 13(1):202. PubMed ID: 27566410
    [Abstract] [Full Text] [Related]

  • 16. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.
    Wong M.
    Exp Neurol; 2013 Jun 26; 244():22-6. PubMed ID: 22015915
    [Abstract] [Full Text] [Related]

  • 17. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
    Guo W, Zhang CQ, Shu HF, Yang MH, Yin Q, Yang H.
    J Mol Neurosci; 2013 May 26; 50(1):7-13. PubMed ID: 22752548
    [Abstract] [Full Text] [Related]

  • 18. Tuberous Sclerosis Complex (TSC) Inactivation Increases Neuronal Network Activity by Enhancing Ca2+ Influx via L-Type Ca2+ Channels.
    Hisatsune C, Shimada T, Miyamoto A, Lee A, Yamagata K.
    J Neurosci; 2021 Sep 29; 41(39):8134-8149. PubMed ID: 34417327
    [Abstract] [Full Text] [Related]

  • 19. Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology.
    Ess KC, Uhlmann EJ, Li W, Li H, Declue JE, Crino PB, Gutmann DH.
    Glia; 2004 Apr 01; 46(1):28-40. PubMed ID: 14999811
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.